PRVB - Provention Bio, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5722.67M
Enterprise Value 3627.59M
Trailing P/E N/A
Forward P/E 1-12.97
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)7.91
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3581.42%
S&P500 52-Week Change 321.60%
52 Week High 322.82
52 Week Low 32.20
50-Day Moving Average 315.60
200-Day Moving Average 310.65

Share Statistics

Avg Vol (3 month) 3688.3k
Avg Vol (10 day) 3406.36k
Shares Outstanding 547.64M
Float 30.14M
% Held by Insiders 128.00%
% Held by Institutions 121.32%
Shares Short (Jan 30, 2020) 41.92M
Short Ratio (Jan 30, 2020) 42.87
Short % of Float (Jan 30, 2020) 46.20%
Short % of Shares Outstanding (Jan 30, 2020) 44.04%
Shares Short (prior month Dec 30, 2019) 41.97M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-30.49%
Return on Equity (ttm)-49.11%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-38.43M
Diluted EPS (ttm)-1.01
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)95.09M
Total Cash Per Share (mrq)2
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)19.43
Book Value Per Share (mrq)1.92

Cash Flow Statement

Operating Cash Flow (ttm)-32.1M
Levered Free Cash Flow (ttm)-18.48M